Dimebon Slows Progression of Proteinopathy in Γ-Synuclein Transgenic Mice

Neurotoxicity Research - United States
doi 10.1007/s12640-011-9299-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Increased Cholinergic Response in Α-Synuclein Transgenic Mice (H-Α-synL62)

ACS Chemical Neuroscience
BiochemistryMedicinePhysiologyCell BiologyCognitive Neuroscience
2018English

Distinct Region-Specific -Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration

Journal of Neuroscience
Neuroscience
2010English

Rapamycin Slows Aging in Mice

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Rapamycin Slows Aging in Mice

Aging Cell
AgingCell Biology
2012English

High-Intensity Interval Training Slows Down Tumor Progression in Mice Bearing Lewis Lung Carcinoma

JCSM Rapid Communications
2018English

Parkinson's Disease -Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Journal of Neuroscience
Neuroscience
2006English

Robust Central Nervous System Pathology in Transgenic Mice Following Peripheral Injection of Α-Synuclein Fibrils

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2016English

Impaired Reproduction in Transgenic Mice Overexpressing Γ-Aminobutyric Acid Transporter I (GAT1)

Cell Research
Cell BiologyMolecular Biology
2004English

Lack of Nigral Pathology in Transgenic Mice Expressing Human Α-Synuclein Driven by the Tyrosine Hydroxylase Promoter

Neurobiology of Disease
Neurology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy